Weight loss support designed for midlife.

What actually changes when menopause begins

Menopause is not one event. It is a transition that often spans 7 to 14 years. Perimenopause begins for most women in their early to mid 40s. Menopause itself is the moment a woman has gone 12 months without a period. Postmenopause is everything after.

Across this window your body goes through several real shifts that affect weight in ways that have nothing to do with effort or willpower. Estrogen drops. Progesterone drops. Insulin sensitivity tends to decline. Cortisol patterns shift. Sleep gets choppier. Lean muscle mass quietly decreases at a rate of roughly 1 percent per year unless something is actively countering it. The result is a new metabolic baseline that the old playbook does not match.

How estrogen shapes where fat lives

Before menopause, women tend to store fat in the hips and thighs. This pattern is sometimes called gynoid distribution. After menopause, the pattern shifts. Fat moves toward the abdomen and around the organs. This is called visceral fat, and it behaves very differently than subcutaneous fat.

Visceral fat is metabolically active. It releases inflammatory signals, interferes with insulin receptors, and increases the risk of cardiovascular disease and type 2 diabetes. Falling estrogen is one of the main reasons this redistribution happens. The number on the scale may not change much in early perimenopause, but body composition often does.

The quiet muscle loss most women never hear about

Sarcopenia is age-related loss of muscle. It accelerates around menopause. For most women it is silent. Clothes still fit. The mirror still looks similar. But basal metabolism drops, strength declines, and the body becomes less efficient at handling carbohydrates.

The implications are practical. A woman who could eat 2,000 calories a day at 35 may now maintain weight on 1,700. Same body, same routine, different math. The honest answer is not to eat less and work out more. The honest answer is to rebuild what is being lost.

Where GLP-1 medications fit into the menopause picture

GLP-1 medications were originally developed for type 2 diabetes. More recently they were approved for chronic weight management. The brand-name products you may have heard of include Wegovy (semaglutide) and Zepbound (tirzepatide). They are not FDA-approved as a treatment for menopausal weight gain specifically. But the underlying mechanisms address several things that menopause makes harder.

GLP-1 acts on receptors in the brain that control appetite. It slows gastric emptying so meals leave you feeling fuller for longer. It improves insulin sensitivity, which is exactly the system that becomes less responsive after menopause. For some women, the result is a quieter relationship with food after years of constant hunger battles.

None of this happens automatically. None of it is guaranteed. And it is not a substitute for the foundational work. But for women whose metabolic system has shifted, it can be one part of a real plan.

What the research has examined

Most large GLP-1 weight loss trials enrolled adults with obesity or overweight plus a related health condition. Many of those participants were women in midlife. Results from those trials are reported as averages, and individual response varies widely.

• STEP trials (semaglutide). Brand-name semaglutide produced average body weight reductions in the 15 to 17 percent range over 68 weeks in trial participants who completed the study.
• SURMOUNT trials (tirzepatide). Brand-name tirzepatide produced average body weight reductions of up to 22.5 percent at the highest dose over 72 weeks in trial participants who completed the study.
• Smaller subgroup analyses. Some research has looked specifically at how women in different life stages responded. Subgroup analyses are smaller and less definitive than the headline results.

These findings describe brand-name FDA-approved products. They do not describe compounded versions, which have not been studied the same way, and they are not promises of any individual outcome.

GLP-1 is one piece. The plan that actually works.

The women who do best with GLP-1 in midlife do not treat it as a standalone fix. They build the rest of the plan around it.

Strength training, twice a week minimum

The single most important thing you can do for menopausal metabolism is build muscle. Strength training improves insulin sensitivity, raises basal metabolic rate, protects bones, and reverses the sarcopenia that menopause accelerates. Two to three sessions per week with compound lifts (squats, hinges, presses, rows) is the standard recommendation.

Protein intake that matches the body you want

Protein needs go up in midlife, not down. Most clinicians recommend somewhere between 0.7 and 1 gram of protein per pound of body weight for active women in this stage. Protein protects muscle, helps with satiety, and supports the metabolic system you are trying to keep.

Sleep, even when it is hard

Hot flashes and night sweats interrupt sleep for most women in perimenopause and early menopause. Poor sleep worsens insulin resistance and pushes hunger hormones in the wrong direction. Talk to your provider about hormone therapy, sleep environment changes, or other options if your sleep is broken. This matters more than any supplement on the market.

Hormone therapy when appropriate

Modern hormone therapy is not the dangerous monolith it was once portrayed as. For many women, bioidentical hormone therapy under the supervision of a knowledgeable provider can dramatically improve quality of life, sleep, and even body composition. It is not for everyone, and it is not without risks. But it deserves a real conversation, not a reflexive no.

Labs that actually tell you something

Ask for fasting insulin, HbA1c, lipid panel, free and total testosterone, estradiol, progesterone, FSH, vitamin D, ferritin, and a full thyroid panel including TSH, free T3, free T4, and reverse T3. These give a real baseline. The scale is one number. Your labs tell the actual story.

What to know about side effects

The most commonly reported side effects from GLP-1 trials of brand-name products were gastrointestinal: nausea, constipation, diarrhea, and reduced appetite. Most are mild to moderate and most improve as the body adjusts. Dose escalation is gradual for exactly this reason.

Some patients also report fatigue or mood changes during dose adjustments. There are also rare but serious risks that your provider should walk you through, including specific contraindications. The conversation with a real licensed physician is the entire point of going through a telehealth platform with provider review rather than a no-questions delivery service.

Who is NOT a good candidate

• A personal or family history of medullary thyroid carcinoma or MEN2.
• A personal history of pancreatitis.
• Pregnancy or breastfeeding. GLP-1 medications are contraindicated.
• Active or recent cancer.
• Severe gastroparesis or other significant gastrointestinal disease.
• Active eating disorder.
• Certain medications that interact significantly with GLP-1.

If a Puri-affiliated provider declines to prescribe, they will explain why and you will not be charged for medication you did not receive. Most women who do not qualify for GLP-1 still have good options. Talk to your provider about what those look like for you.

How to think about the decision

• Start with labs, not the scale. Know your baseline before you change anything.
• Pick the muscle work first. Strength training compounds over years and protects the metabolic system you are trying to keep.
• Sleep is medicine. Almost no plan works on broken sleep.
• Consider GLP-1 as a tool, not the answer. It works best alongside the rest of the plan, not instead of it.
• Find a provider who actually listens. Midlife women have spent decades being dismissed. Settle for less only at your own cost.

When you are ready, start your assessment. A licensed physician usually reviews intakes within 24 hours.